Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 9 (1), 10-6

Dead Bugs Don't Mutate: Susceptibility Issues in the Emergence of Bacterial Resistance


Dead Bugs Don't Mutate: Susceptibility Issues in the Emergence of Bacterial Resistance

Charles W Stratton. Emerg Infect Dis.


The global emergence of antibacterial resistance among common and atypical respiratory pathogens in the last decade necessitates the strategic application of antibacterial agents. The use of bactericidal rather than bacteriostatic agents as first-line therapy is recommended because the eradication of microorganisms serves to curtail, although not avoid, the development of bacterial resistance. Bactericidal activity is achieved with specific classes of antimicrobial agents as well as by combination therapy. Newer classes of antibacterial agents, such as the fluoroquinolones and certain members of the macrolide/lincosamine/streptogramin class have increased bactericidal activity compared with traditional agents. More recently, the ketolides (novel, semisynthetic, erythromycin-A derivatives) have demonstrated potent bactericidal activity against key respiratory pathogens, including Streptococcus pneumoniae, Haemophilus influenzae, Chlamydia pneumoniae, and Moraxella catarrhalis. Moreover, the ketolides are associated with a low potential for inducing resistance, making them promising first-line agents for respiratory tract infections.

Similar articles

See all similar articles

Cited by 40 PubMed Central articles

See all "Cited by" articles


    1. Ashhurst AP The centenary of Lister (1827–1927). A tale of sepsis and antisepsis. Ann Med Hist 1927;9:205–11
    1. Neu HC Antimicrobial chemotherapy, 1934–1994. Antimicrobics and Infectious Diseases Newsletter 1994;13:1–8 10.1016/1069-417X(94)90006-X - DOI
    1. Neu HC The crisis in antibiotic resistance. Science 1992;257:1064–73 10.1126/science.257.5073.1064 - DOI - PubMed
    1. Levy SB The antibiotic paradox: how miracle drugs are destroying the miracle. New York: Plenum; 1992
    1. Kunin CM Resistance to antimicrobial drugs: a worldwide calamity. Ann Intern Med 1993;118:557–61 - PubMed

MeSH terms

LinkOut - more resources